Free Trial
CVE:LBL

Lattice Biologics (LBL) Stock Price, News & Analysis

C$0.04 0.00 (0.00%)
As of 06/3/2021

About Lattice Biologics Stock (CVE:LBL)

Key Stats

Today's Range
C$0.04
C$0.04
50-Day Range
C$0.04
C$0.04
52-Week Range
C$0.03
C$0.13
Volume
114,000 shs
Average Volume
468,022 shs
Market Capitalization
C$5.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lattice Biologics and its competitors with MarketBeat's FREE daily newsletter.

LBL Stock News Headlines

Best Lattice Alternatives Of 2024
IVBIY Innovent Biologics, Inc.
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Lattice Biologics Ltd (LBLh)
Lattice Semiconductor Corp LSCC Stock Quote
See More Headlines

LBL Stock Analysis - Frequently Asked Questions

Lattice Biologics' stock was trading at C$0.04 at the beginning of 2025. Since then, LBL shares have increased by 0.0% and is now trading at C$0.04.

Shares of LBL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lattice Biologics investors own include 50904 (GRC.V) (GRC), Air Canada (AC), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Antibe Therapeutics (ATE) and BioCryst Pharmaceuticals (BCRX).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:LBL
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.02
Quick Ratio
0.02

Sales & Book Value

Annual Sales
C$1.56 million
Price / Sales
3.29
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
C$0.00 per share
Price / Book
40.00

Miscellaneous

Outstanding Shares
128,218,000
Free Float
N/A
Market Cap
C$5.13 million
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (CVE:LBL) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners